Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Skin fat helps with body temperature control and has other active roles in health.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.